FDA invites comments on their Guidance for Clinical Trial Sponsors:

Establishment and Operation of Clinical Trial Data Monitoring Committees

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on the collection of information concerning the establishment and operation of clinical trial data monitoring committees.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /